IL2RG and colorectal adenocarcinoma: Based on a previously developed model [18], [40], we employed immunodeficient NOD SCID IL2Rγ−/− (NSG) mice for the engraftment of 5T4+ human HT-29 colorectal adenocarcinoma cells.